Tech Company Inital Public Offerings
Receptos IPO
Receptos was bought by . Shares started trading on 5/10/2013.
Transaction Overview
Company Name
Announced On
5/10/2013
Transaction Type
IPO
Amount
$72,800,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
10835 Road to the Cure 205
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Receptos is developing the next generation in GPCR drug discovery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Faheem Hasnain
Chief Medical Officer
Sheila Gujrathi
Chief Scientific Officer
Robert Peach
Chief Technical Officer
Marcus Boehm
VP - Bus. Development
Chrysa Mineo
Browse more venture capital transactions:
Prev: 5/10/2013: MadeiraCloud venture capital transaction
Next: 5/10/2013: Merchantry venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs